Selected article for: "amino acid and antiviral compound"
Author: Zou, Gang; Puig-Basagoiti, Francesc; Zhang, Bo; Qing, Min; Chen, Liqiang; Pankiewicz, Krzysztof W.; Felczak, Krzysztof; Yuan, Zhiming; Shi, Pei-Yong
Title: A single-amino acid substitution in West Nile virus 2K peptide between NS4A and NS4B confers resistance to lycorine, a flavivirus inhibitor
  • Cord-id: lbjwyyl1
  • Document date: 2009_2_1
    • ID: lbjwyyl1
    Snippet: Lycorine potently inhibits flaviviruses in cell culture. At 1.2-μM concentration, lycorine reduced viral titers of West Nile (WNV), dengue, and yellow fever viruses by 10(2)- to 10(4)-fold. However, the compound did not inhibit an alphavirus (Western equine encephalitis virus) or a rhabdovirus (vesicular stomatitis virus), indicating a selective antiviral spectrum. The compound exerts its antiviral activity mainly through suppression of viral RNA replication. A Val→Met substitution at the 9th
    Document: Lycorine potently inhibits flaviviruses in cell culture. At 1.2-μM concentration, lycorine reduced viral titers of West Nile (WNV), dengue, and yellow fever viruses by 10(2)- to 10(4)-fold. However, the compound did not inhibit an alphavirus (Western equine encephalitis virus) or a rhabdovirus (vesicular stomatitis virus), indicating a selective antiviral spectrum. The compound exerts its antiviral activity mainly through suppression of viral RNA replication. A Val→Met substitution at the 9th amino acid position of the viral 2K peptide (spanning the endoplasmic reticulum membrane between NS4A and NS4B proteins) confers WNV resistance to lycorine, through enhancement of viral RNA replication. Initial chemistry synthesis demonstrated that modifications of the two hydroxyl groups of lycorine can increase the compound’s potency, while reducing its cytotoxicity. Taken together, the results have established lycorine as a flavivirus inhibitor for antiviral development. The lycorine-resistance results demonstrate a direct role of the 2K peptide in flavivirus RNA synthesis.

    Search related documents:
    Co phrase search for related documents
    • absence presence and addition time: 1
    • absence presence and loading control: 1, 2, 3
    • absence presence and luciferase activity: 1, 2, 3, 4, 5
    • action mode analysis and acute respiratory: 1, 2
    • action mode analysis and addition time: 1
    • action mode and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • action mode and addition time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • action mode and addition time experiment: 1, 2
    • action mode and low antiviral potency: 1, 2
    • action mode and luciferase activity: 1, 2
    • acute respiratory and addition time: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory and addition time experiment: 1
    • acute respiratory and long polyprotein: 1, 2
    • acute respiratory and low antiviral potency: 1, 2
    • acute respiratory and low viral titer: 1, 2, 3, 4
    • acute respiratory and luciferase activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • acute respiratory and luciferase activity assay: 1, 2, 3, 4
    • addition time and luciferase activity: 1, 2, 3
    • addition time experiment and luciferase activity: 1